Cell morphology best predicts tumorigenicity and metastasis in vivo across multiple TNBC cell lines of different metastatic potential
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Cell morphology best predicts tumorigenicity and metastasis in vivo across multiple TNBC cell lines of different metastatic potential ; volume:26 ; number:1 ; day:11 ; month:3 ; year:2024 ; pages:1-16 ; date:12.2024
Breast cancer research ; 26, Heft 1 (11.3.2024), 1-16, 12.2024
- Urheber
-
Conner, Sydney J.
Guarin, Justinne R.
Le, Thanh T.
Fatherree, Jackson P.
Kelley, Charlotte
Payne, Samantha L.
Parker, Savannah R.
Bloomer, Hanan
Zhang, Crystal
Salhany, Kenneth
McGinn, Rachel A.
Henrich, Emily
Yui, Anna
Srinivasan, Deepti
Borges, Hannah
Oudin, Madeleine J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-024-01796-8
- URN
-
urn:nbn:de:101:1-2405140823599.613760985260
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-14T11:02:23+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Conner, Sydney J.
- Guarin, Justinne R.
- Le, Thanh T.
- Fatherree, Jackson P.
- Kelley, Charlotte
- Payne, Samantha L.
- Parker, Savannah R.
- Bloomer, Hanan
- Zhang, Crystal
- Salhany, Kenneth
- McGinn, Rachel A.
- Henrich, Emily
- Yui, Anna
- Srinivasan, Deepti
- Borges, Hannah
- Oudin, Madeleine J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neural stemness contributes to cell tumorigenicity
Cell softness regulates tumorigenicity and stemness of cancer cells
PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
FOXP1inhibits cell growth and attenuates tumorigenicity of neuroblastoma
Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells
Loss of tumorigenicity by transdifferentiation : from squamous cell carcinoma to melanocyte-like cells
Loss of tumorigenicity by transdifferentiation:from squamous cell carcinoma to melanocyte-like cells
Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells
SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells
RACK1 promotes tumorigenicity of colon cancer by inducing cell autophagy
Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells
TAZ maintains telomere length in TNBC cells by mediating Rad51C expression
Neural stemness contributes to cell tumorigenicity
Cell softness regulates tumorigenicity and stemness of cancer cells
PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
FOXP1inhibits cell growth and attenuates tumorigenicity of neuroblastoma
Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells
Loss of tumorigenicity by transdifferentiation : from squamous cell carcinoma to melanocyte-like cells
Loss of tumorigenicity by transdifferentiation:from squamous cell carcinoma to melanocyte-like cells
Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells
SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells
RACK1 promotes tumorigenicity of colon cancer by inducing cell autophagy
Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells
TAZ maintains telomere length in TNBC cells by mediating Rad51C expression
Neural stemness contributes to cell tumorigenicity
Cell softness regulates tumorigenicity and stemness of cancer cells
PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
FOXP1inhibits cell growth and attenuates tumorigenicity of neuroblastoma
Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells
Loss of tumorigenicity by transdifferentiation : from squamous cell carcinoma to melanocyte-like cells
Loss of tumorigenicity by transdifferentiation:from squamous cell carcinoma to melanocyte-like cells
Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells
SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells
RACK1 promotes tumorigenicity of colon cancer by inducing cell autophagy
Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells